Cunha and collaborators have compiled in different reviews the potential of targeting A2AR in both neurons and microglia to combat cognition and/or neurodegeneration in Alzheimer’s disease and other age-related dementias [45,46]. Here, ADORA2A is linked to early-onset autosomal dominant Alzheimer disease.